Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapivirine Vaginal Ring and Oral Truvada in Breastfeeding Mother-Infant Pairs
NCT04140266Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of dapivirine, emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 2020; status: completed.
02
Drugs
dapivirineemtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04140266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04140266.